BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 23113654)

  • 1. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients.
    Honohan A; Tomson B; van der Bom J; de Vries R; Brand A
    Transfusion; 2012 Apr; 52(4):742-51. PubMed ID: 21981629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
    Gelb AB; Leavitt AD
    Transfusion; 1997 Jun; 37(6):624-30. PubMed ID: 9191823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
    Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.
    Janetzko K; Cazenave JP; Klüter H; Kientz D; Michel M; Beris P; Lioure B; Hastka J; Marblie S; Mayaudon V; Lin L; Lin JS; Conlan MG; Flament J
    Transfusion; 2005 Sep; 45(9):1443-52. PubMed ID: 16131376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.
    Bakchoul T; Bassler D; Heckmann M; Thiele T; Kiefel V; Gross I; Arnold DM; DiTomasso J; Smith JW; Paes B; Greinacher A
    Transfusion; 2014 Mar; 54(3):640-5. PubMed ID: 23869512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
    Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
    Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion.
    Rioux-Massé B; Cohn C; Lindgren B; Pulkrabek S; McCullough J
    Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.
    Gavva C; Barroso J; Gernsheimer T; Metcalf RA; Warner P; Pagano MB
    Transfusion; 2019 Jul; 59(7):2276-2281. PubMed ID: 31032968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-negative solid-phase platelet crossmatch results due to prozone phenomenon.
    Horton RK; Zuccarelli MD; Wakefield LL; DiGuardo MA; Gandhi MJ; Juskewitch JE
    Transfusion; 2020 Dec; 60(12):3055-3059. PubMed ID: 33047855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review.
    Vassallo RR; Fung M; Rebulla P; Duquesnoy R; Saw CL; Slichter SJ; Tanael S; Shehata N;
    Transfusion; 2014 Apr; 54(4):1180-91. PubMed ID: 24032995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
    Lo SC; Chang JS; Lin SW; Lin DT
    Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies.
    Maurer-Spurej E; Labrie A; Pittendreigh C; Chipperfield K; Smith C; Heddle N; Liu Y; Yi QL; Barnett M
    Transfusion; 2009 Nov; 49(11):2276-84. PubMed ID: 19903289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.